Dishman Carbogen Amcis Limited Appoints New Vice President of Operations
Noor Mohmmed
11/Jan/2025

What's Covered
- Deepak Mittal joins Dishman Carbogen Amcis Limited as Vice President (Operations).
- Brings 30 years of expertise in API production, project management, and compliance.
- Appointment follows Nomination and Remuneration Committee's approval.
Dishman Carbogen Amcis Limited, a renowned pharmaceutical company, has announced the appointment of Mr. Deepak Ram Chandra Mittal as its new Vice President (Operations), effective January 10, 2025. This strategic hire is expected to bolster the company’s operational capabilities and strengthen its position in the pharmaceutical sector.
Key Details
- Role: Vice President (Operations)
- Effective Date: January 10, 2025
- Approval: As per the Nomination and Remuneration Committee's policy
Deepak Mittal’s Profile
Mr. Mittal, aged 55, is a seasoned professional with 30 years of extensive experience in various aspects of the pharmaceutical industry. He holds an M. Tech. and a Master's degree in Management, equipping him with a robust academic foundation for his role.
Expertise and Experience
- Bulk Drug API Production: Expertise in production, process engineering, and technology transfer
- Project Management: Proficient in scale-up operations, solvent recovery, and commissioning of advanced systems
- Regulatory Audits and Compliance: Well-versed in cGMP practices and audit preparation for global regulatory requirements
- Lean Methodologies: Skilled in implementing Lean Sigma and conducting root cause analyses
Prior to joining Dishman Carbogen, Mr. Mittal served as Vice President - Operations at Arch Pharma Labs Ltd., where he led several key projects, including the commissioning of cutting-edge distillation columns and optimization of solvent recovery operations.
Impact on Dishman Carbogen Amcis Limited
The appointment aligns with the company’s commitment to enhancing its operational efficiency and regulatory compliance. With his vast expertise, Mr. Mittal is expected to drive innovation and ensure adherence to the highest standards in pharmaceutical manufacturing.
Compliance with SEBI Regulations
This announcement complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The company has ensured that all required disclosures have been made transparently.
For more information, visit Dishman Carbogen’s website.
The Upcoming IPOs in this week and coming weeks are Kabra Jewels and Laxmi Dental.
The Current active IPO are Sat Kartar Shopping and Barflex Polyfilms.